RemsimaTM extended clinical trial study was disclosed in EULAR 2013 PipelineReview.com (press release) INCHEON, South Korea I June 16, 2013 I In the EULAR 2013, Celltrion disclosed extended clinical trial phase 1 & phase 3 study results through a poster session and oral presentation. According to these study result, RemsimaTM demonstrated clinical ... |
